Last Updated: June 24, 2026

VALPROIC Drug Patent Profile

Name: VALPROIC Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Valproic, and when can generic versions of Valproic launch?

Valproic is a drug marketed by Bionpharma, Catalent, Chartwell Rx, Hibrow Hlthcare, Par Pharm, Scherer Rp, Sun Pharm Inds Ltd, Ani Pharms, Hikma, Lannett Co Inc, Pai Holdings, Pharm Assoc, Pharmobedient Cnsltg, and Quagen. and is included in fifteen NDAs.

The generic ingredient in VALPROIC is valproic acid. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Valproic

A generic version of VALPROIC was approved as valproic acid by CATALENT on October 29^th, 1991.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for VALPROIC?
What are the global sales for VALPROIC?
What is Average Wholesale Price for VALPROIC?

Summary for VALPROIC

US Patents:	0
Applicants:	14
NDAs:	15
Drug Prices:	Drug price information for VALPROIC
DailyMed Link:	VALPROIC at DailyMed

Drug patent expirations by year for VALPROIC

US Patents and Regulatory Information for VALPROIC

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bionpharma	VALPROIC ACID	valproic acid	CAPSULE;ORAL	073484-001	Jun 29, 1993	AB	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharm Inds Ltd	VALPROIC ACID	valproic acid	CAPSULE;ORAL	091037-001	Feb 22, 2013		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hibrow Hlthcare	VALPROIC ACID	valproic acid	CAPSULE;ORAL	207611-001	Aug 5, 2019		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for VALPROIC

Depakine valproic acid excipients fda dailymed?
Valproic acid vs depakote?
Valproic acid bp manufacturer?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.